Advanced search
Publication Cover
Acta Oto-Laryngologica Volume 144, 2024 - Issue 1
Submit an article Journal homepage
502
Views
0
CrossRef citations to date
0
Altmetric
Larynx

Human papilloma virus (HPV) vaccination is associated with reduced number of surgical treatments, an observational study on recurrent respiratory papillomatosis in Northern Sweden

Alexandra Schindelea Department of Clinical Sciences, Otorhinolaryngology, Umeå University, Östersund, SwedenCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0003-0007-8716
ORCID Icon,
Semma Al-Sabttib Department of Clinical Sciences, Otorhinolaryngology, Umeå University, Umeå, Sweden
&
Katarina Olofssonb Department of Clinical Sciences, Otorhinolaryngology, Umeå University, Umeå, SwedenORCID Iconhttps://orcid.org/0000-0002-0649-3825
ORCID Icon
Pages 71-75 | Received 21 Nov 2023, Accepted 05 Feb 2024, Published online: 04 Mar 2024

References

  • Derkay CS, Bluher AE. Update on recurrent respiratory papillomatosis. Otolaryngol Clin North Am. 2019; Aug52(4):669–679. doi:10.1016/j.otc.2019.03.011.
  • Loizou C, Laurell G, Lindquist D, et al. Voice and quality of life in patients with recurrent respiratory papillomatosis in a Northern Sweden cohort. Acta Otolaryngol. 2014;134(4):401–406. Apr doi:10.3109/00016489.2013.867457.
  • Omland T, Akre H, Vårdal M, et al. Epidemiological aspects of recurrent respiratory papillomatosis: a population-based study. Laryngoscope. 2012;122(7):1595–1599. Jul doi:10.1002/lary.23327.
  • Bishai D, Kashima H, Shah K. The cost of juvenile-onset recurrent respiratory papillomatosis. Arch Otolaryngol Head Neck Surg. 2000; Aug126(8):935–939. doi:10.1001/archotol.126.8.935.
  • Omland T, Akre H, Lie KA, et al. Risk factors for aggressive recurrent respiratory papillomatosis in adults and juveniles. pLoS One. 2014;9(11):e113584. doi:10.1371/journal.pone.0113584.
  • de Martel C, Plummer M, Vignat J, et al. Worldwide burden of cancer attributable to HPV by site, country and HPV type. Int J Cancer. 2017;141(4):664–670. Aug 15 doi:10.1002/ijc.30716.
  • Novakovic D, Cheng ATL, Zurynski Y, et al. A prospective study of the incidence of juvenile-onset recurrent respiratory papillomatosis after implementation of a national HPV vaccination program. J Infect Dis. 2018;217(2):208–212. Jan 4 doi:10.1093/infdis/jix498.
  • Wikström A, Elfgren K. [HPV vaccines effective and safe.] Lakartidningen. 2021;118:21061.
  • Folkhälsomyndigheten. HPV-vaccinuppföljning Folkhälsomyndigheten 2022 [updated 2022-12-16; cited 2023 01-31]. Available from: https://www.folkhalsomyndigheten.se/smittskydd-beredskap/vaccinationer/nationella-vaccinationsprogram/uppfoljning-av-vaccinationsprogram/hpv-vaccinuppfoljning/.
  • von Elm E, Altman DG, Egger M, et al. The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. Int J Surg. 2014;12(12):1495–1499. Dec doi:10.1016/j.ijsu.2014.07.013.
  • Young DL, Moore MM, Halstead LA. The use of the quadrivalent human papillomavirus vaccine (gardasil) as adjuvant therapy in the treatment of recurrent respiratory papilloma. J Voice. 2015; Mar29(2):223–229. doi:10.1016/j.jvoice.2014.08.003.
  • Helmstaedter V, Tellkamp R, Majdani O, et al. High-frequency jet ventilation for endolaryngotracheal surgery–chart review and procedure analysis from the surgeon’s and the anaesthesiologist’s point of view. Clin Otolaryngol. 2015;40(4):341–348. Aug doi:10.1111/coa.12376.
  • Okoshi K, Kobayashi K, Kinoshita K, et al. Health risks associated with exposure to surgical smoke for surgeons and operation room personnel. Surg Today. 2015;45(8):957–965. Aug doi:10.1007/s00595-014-1085-z.
  • Holm A, Nagaeva O, Nagaev I, et al. Lymphocyte profile and cytokine mRNA expression in peripheral blood mononuclear cells of patients with recurrent respiratory papillomatosis suggest dysregulated cytokine mRNA response and impaired cytotoxic capacity. Immun Inflamm Dis. 2017;5(4):541–550. Dec doi:10.1002/iid3.188.
  • Rosenberg T, Philipsen BB, Mehlum CS, et al. Therapeutic use of the human papillomavirus vaccine on recurrent respiratory papillomatosis: a systematic review and Meta-Analysis. J Infect Dis. 2019;219(7):1016–1025. Mar 15 doi:10.1093/infdis/jiy616.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.